Literature DB >> 19439717

Management of aggression among demented or brain-injured patients.

Deborah Finfgeld-Connett1.   

Abstract

Nurses' responses to aggression among patients with dementia or brain injury are not fully informed by evidence-based interventions. For this reason, the primary purpose of this investigation was to delineate a conceptual framework of optimal therapeutic interventions to manage verbal and behavioral aggression among these individuals. Meta-synthesis methods were used, and findings from seven reports of qualitative research were synthesized. Therapeutic management of aggression among patients with dementia or brain injury was captured by the metaphor entering the patient's world. This process involves getting to know the patient behind the aggression and normalizing their experiences. Nurses are encouraged to become a part of the patient's world and to strive for mutual understanding and action. Patient negativity is downplayed and interactions are shaped in thoughtfully creative ways. Therapeutic management of aggression results in positive outcomes for nurses as well as patients.

Entities:  

Mesh:

Year:  2009        PMID: 19439717     DOI: 10.1177/1054773809337577

Source DB:  PubMed          Journal:  Clin Nurs Res        ISSN: 1054-7738            Impact factor:   2.075


  3 in total

1.  Perceived competency and resolution of homelessness among women with substance abuse problems.

Authors:  Deborah Finfgeld-Connett; Tina L Bloom; E Diane Johnson
Journal:  Qual Health Res       Date:  2011-09-02

2.  Revisiting the neurofunctional approach: conceptualizing the core components for the rehabilitation of everyday living skills.

Authors:  Jo Clark-Wilson; Gordon Muir Giles; Doreen M Baxter
Journal:  Brain Inj       Date:  2014-08-25       Impact factor: 2.311

3.  Staff-reported antecedents to aggression in a post-acute brain injury treatment programme: what are they and what implications do they have for treatment?

Authors:  Gordon Muir Giles; Karen Scott; David Manchester
Journal:  Neuropsychol Rehabil       Date:  2013-06-19       Impact factor: 2.868

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.